Boston, MA · Founded 2025 · Privately Held (backing)
Operator of a biotechnology company intended to develop first-in-class precision medicines targeting previously undruggable cancer and serious disease targets. Antares Therapeutics is based in Boston, MA and was founded in 2025. It is valued at about $299 million as of Oct 2026, set by institutional fund marks. It has raised $177 million across 2 recorded rounds; the latest was a $30 million early-stage round in May 2025.
PMV mark · valuation
$299.0M
Oct 2026
Priced at
its early-stage round
Apr 2025
Total raised
$177.0M
Last round
Early Stage VC
May 2025
Team — not yet on record
No current team members for Antares Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Antares Therapeutics with a free account
·The complete investor list: 11 names
·Watch Antares Therapeutics: the Monday email on marks, rounds and moves
